STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY

Published:2024-09 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Gabriella Macchia,Donato Pezzulla,Maura Campitelli,Donatella Russo,Graziana Ronzino,Simona Lucci,Vanda Salutari,Aida Di Stefano,Vittoria Balcet,Valeria Epifani,Elisabetta Perrucci,Claudia Marchetti,Grazia Distefano Maria,Eleonora Palluzzi,Rosa Autorino,Viola De Luca,Roberta Giannini,Raffaella Rinaldi,Andrea Russo Silvio,Savino Cilla,Anna Fagotti,Antonietta Gambacorta Maria,Giovanni Scambia,Francesco Deodato,Gabriella Ferrandina

Publisher

Elsevier BV

Reference39 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. Gynecologic Oncology Group. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N Engl J Med,2011

3. ICON7 Investigators. A phase 3 trial of bevacizumab in ovarian cancer;Perren;N Engl J Med.,2011

4. Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer;Moore;N Engl J Med,2018

5. PRIMA/ENGOT-OV26/GOG-3012 Investigators. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer;González-Martín;N Engl J Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP